Protecting newborns from pertussis - the challenge of complete cocooning

BMC Infectious Diseases

Volumn 14, Issue 1, 2014, Pages

  Urwyler, Pascal ^a   Heininger, Ulrich ^a  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

Bordetella pertussis; Cocooning; Neonates; Pertussis; Vaccine

Indexed keywords

PERTUSSIS VACCINE;

ADULT; ARTICLE; ATTITUDE TO HEALTH; BORDETELLA PERTUSSIS; COCOON STRATEGY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; EDUCATIONAL STATUS; FEMALE; GENERAL PRACTITIONER; GYNECOLOGIST; HEALTH PROGRAM; HUMAN; IMMUNIZATION; MALE; NEWBORN; NEWBORN CARE; OBSTETRICIAN; PARENTAL ATTITUDE; PEDIATRICIAN; PERINATAL PERIOD; PERTUSSIS; QUESTIONNAIRE; STRATEGIC PLANNING; SWITZERLAND; ADOLESCENT; CHILD; HEALTH CARE PLANNING; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MIDDLE AGED; PARENT COUNSELING; PERINATAL CARE; PRESCHOOL CHILD; SCHOOL CHILD; THERAPY;

ADOLESCENT; ADULT; AGED; AGING; CHILD; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH PERSONNEL; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; PARENTS; PERTUSSIS VACCINE; PREGNANCY; QUESTIONNAIRES; SWITZERLAND; WHOOPING COUGH; YOUNG ADULT;

EID: 84904273716     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-14-397     Document Type: Article

References (39)

1. Van Hoek AJ, Campbell H, Amirthalingam G, Andrews N, Miller E. The number of deaths among infants under one year of age in England with pertussis: results of a capture/recapture analysis for the period 2001 to 2011. Euro Surveill 2013, 18(9):20414.
2. Heininger U, Weibel D, Richard JL. Prospective nationwide surveillance of hospitalizations due to pertussis in children, 2006-2010. Pediatr Infect Dis J 2014, 33:147-151.
3. Clark TA. Changing pertussis epidemiology: everything old is new again. J Infect Dis 2014, 209:978-981.
4. Chiappini E, Stival A, Galli L, de Martino M. Pertussis re-emergence in the post-vaccination era. BMC Infect Dis 2013, 13:151.
5. Cherry JD. Epidemic pertussis in 2012 - the resurgence of a vaccine-preventable disease. N Engl J Med 2012, 367:785-787.
6. Wendelboe AM, Njamkepo E, Bourillon A, Floret DD, Gaudelus J, Gerber M, Grimprel E, Greenberg D, Halperin S, Liese J, Muñoz-Rivas F, Teyssou R, Guiso N, Van Rie A. Transmission of Bordetella pertussis to young infants. Pediatr Infect Dis J 2007, 26:293-299.
7. De Greeff SC, Mooi FR, Westerhof A, Verbakel JM, Peeters MF, Heuvelman CJ, Notermans DW, Elvers LH, Schellekens JF, de Melker HE. Pertussis disease burden in the household: how to protect young infants. Clin Infect Dis 2010, 50:1339-1345.
8. Wiley KE, Zuo Y, Macartney KK, McIntyre PB. Sources of pertussis infection in young infants: a review of key evidence informing targeting of the cocoon strategy. Vaccine 2013, 31:618-625.
9. Healy CM, Rench MA, Baker CJ. Implementation of cocooning against pertussis in a high-risk population. Clin Infect Dis 2011, 52:157-162.
10. Frère J, De Wals P, Ovetchkine P, Coïc L, Audibert F, Tapiero B. Evaluation of several approaches to immunize parents of neonates against B. pertussis. Vaccine 2013, 31:6087-6091.
11. Donnan EJ, Fielding JE, Rowe SL, Franklin LJ, Vally H. A cross sectional survey of attitudes, awareness and uptake of the parental pertussis booster vaccine as part of a cocooning strategy, Victoria, Australia. BMC Public Health 2013, 13:676.
12. Bundesamt für Gesundheit Optimierung der Auffrischimpfungen gegen Diphtherie, Tetanus und Pertussis (dT/dTpa) bei Erwachsenen. BAG Bull 2011, 51:1161-1171. [http://www.bag.admin.ch/dokumentation/publikationen/01435/11505], Bundesamt für Gesundheit.
13. Bundesamt für Gesundheit Anpassung der Impfempfehlung gegen Pertussis: für Jugendliche, Säuglinge in Betreuungseinrichtungen und schwangere Frauen. BAG Bull 2013, 9:118-123. [http://www.bag.admin.ch/dokumentation/publikationen/01435/14421/14604/index.html?lang=de&sort=], Bundesamt für Gesundheit.
14. Healy CM, Rench MA, Baker CJ. Importance of timing of maternal combined tetanus, diphtheria, and acellular pertussis (Tdap) immunization and protection of young infants. Clin Infect Dis 2013, 56:539-544.
15. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep 2011, 60:13-15. Centers for Disease Control and Prevention (CDC).
16. Westra TA, de Vries R, Tamminga JJ, Sauboin CJ, Postma MJ. Cost-effectiveness analysis of various pertussis vaccination strategies primarily aimed at protecting infants in the Netherlands. Clin Ther 2010, 32:1479-1495.
17. Skowronski DM, Janjua NZ, Tsafack EP, Ouakki M, Hoang L, De Serres G. The number needed to vaccinate to prevent infant pertussis hospitalization and death through parent cocoon immunization. Clin Infect Dis 2012, 54:318-327.
18. Lugnér AK, van der Maas N, van Boven M, Mooi FR, de Melker HE. Cost-effectiveness of targeted vaccination to protect newborns against pertussis: comparing neonatal, maternal, and cocooning vaccination strategies. Vaccine 2013, 31:5392-5397.
19. Warfel JM, Zimmerman LI, Merkel TJ. Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model. Proc Natl Acad Sci U S A 2014, 111:787-792.
20. Smallridge WE, Rolin OY, Jacobs NT, Harvill ET. Different effects of whole-cell and acellular vaccines on Bordetella transmission. J Infect Dis 2014, [Epub ahead of print].
21. ISCED classification. [http://www.uis.unesco.org/Education/Pages/international-standard-classification-of-education.aspx].
22. Beel ER, Rench MA, Montesinos DP, Mayes B, Healy CM. Knowledge and attitudes of postpartum women toward immunization during pregnancy and the peripartum period. Hum Vaccin Immunother 2013, 9:1926-1931.
23. Rossmann Beel E, Rench MA, Montesinos DP, Healy CM. Acceptability of immunization in adult contacts of infants: possibility of expanding platforms to increase adult vaccine uptake. Vaccine 2014, [Epub ahead of print].
24. Heininger U, Riffelmann M, Bär G, Rudin C, von König CH. The protective role of maternally derived antibodies against Bordetella pertussis in young infants. Pediatr Infect Dis J 2013, 32:695-698.
25. Castagnini LA, Healy CM, Rench MA, Wootton SH, Munoz FM, Baker CJ. Impact of maternal postpartum tetanus and diphtheria toxoids and acellular pertussis immunization on infant pertussis infection. Clin Infect Dis 2012, 54:78-84.
26. Wiley KE, Massey PD, Cooper SC, Wood N, Quinn HE, Leask J. Pregnant women's intention to take up a post-partum pertussis vaccine, and their willingness to take up the vaccine while pregnant: a cross sectional survey. Vaccine 2013, 31:3972-3978.
27. Terranella A, Asay GR, Messonnier ML, Clark TA, Liang JL. Pregnancy dose Tdap and postpartum cocooning to prevent infant pertussis: a decision analysis. Pediatrics 2013, 131:1748-1756.
28. De Greeff SC, de Melker HE, Westerhof A, Schellekens JF, Mooi FR, van Boven M. Estimation of household transmission rates of pertussis and the effect of cocooning vaccination strategies on infant pertussis. Epidemiology 2012, 23:852-860.
29. Van Hoek AJ, Andrews N, Campbell H, Amirthalingam G, Edmunds WJ, Miller E. The social life of infants in the context of infectious disease transmission; social contacts and mixing patterns of the very young. PLoS One 2013, 8:e76180.
30. Bundesamt für Statistik Bildungsstand der Wohnbevölkerung nach Alter und Geschlecht. [http://www.bfs.admin.ch/bfs/portal/de/index/themen/20/05/blank/key/gleichstellung_und/bildungsstand.html], Bundesamt für Statistik.
31. Bundesamt für Statistik Bilanz der ständigen Wohnbevölkerung nach Staatsangehörigkeit. [http://www.bfs.admin.ch/bfs/portal/de/index/themen/01/07/blank/key/01/01.html], Bundesamt für Statistik.
32. Rivero-Santana A, Cuéllar-Pompa L, Sánchez-Gómez LM, Perestelo-Pérez L, Serrano-Aguilar P. Effectiveness and cost-effectiveness of different immunization strategies against whooping cough to reduce child morbidity and mortality. Health Policy 2014, 115:82-91.
33. Belloni C, De Silvestri A, Tinelli C, Avanzini MA, Marconi M, Strano F, Rondini G, Chirico G. Immunogenicity of a three-component acellular pertussis vaccine administered at birth. Pediatrics 2003, 111:1042-1045.
34. Halasa NB, O'Shea A, Shi JR, LaFleur BJ, Edwards KM. Poor immune responses to a birth dose of diphtheria, tetanus, and acellular pertussis vaccine. J Pediatr 2008, 153:327-332.
35. Siegrist CA. Blame vaccine interference, not neonatal immunization, for suboptimal responses after neonatal diphtheria, tetanus, and acellular pertussis immunization. J Pediatr 2008, 153:305-307.
36. Shinall MC, Peters TR, Zhu Y, Chen Q, Poehling KA. Potential impact of acceleration of the pertussis vaccine primary series for infants. Pediatrics 2008, 122:1021-1026.
37. Thorstensson R, Trollfors B, Al-Tawil N, Jahnmatz M, Bergström J, Ljungman M, Törner A, Wehlin L, Van Broekhoven A, Bosman F, Debrie AS, Mielcarek N, Locht C. A phase I clinical study of a live attenuated Bordetella pertussis vaccine-BPZE1; a single centre, double-blind, placebo-controlled, dose-escalating study of BPZE1 given intranasally to healthy adult male volunteers. PLoS One 2014, 9:e83449.
38. Robbins JB, Schneerson R, Kubler-Kielb J, Keith JM, Trollfors B, Vinogradov E, Shiloach J. Toward a new vaccine for pertussis. Proc Natl Acad Sci U S A 2014, 111:3213-3216.
39. Plotkin SA. The pertussis problem. Clin Infect Dis 2014, 58:830-833.